BCAB
Price
$0.21
Change
+$0.02 (+10.53%)
Updated
Feb 4 closing price
Capitalization
13.23M
42 days until earnings call
Intraday BUY SELL Signals
QNCX
Price
$0.16
Change
+$0.01 (+6.67%)
Updated
Feb 4 closing price
Capitalization
8.85M
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAB vs QNCX

Header iconBCAB vs QNCX Comparison
Open Charts BCAB vs QNCXBanner chart's image
BioAtla
Price$0.21
Change+$0.02 (+10.53%)
Volume$1.8M
Capitalization13.23M
Quince Therapeutics
Price$0.16
Change+$0.01 (+6.67%)
Volume$5.15M
Capitalization8.85M
BCAB vs QNCX Comparison Chart in %
BCAB
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCAB vs. QNCX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Hold and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (BCAB: $0.21 vs. QNCX: $0.16)
Brand notoriety: BCAB and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 76% vs. QNCX: 189%
Market capitalization -- BCAB: $13.23M vs. QNCX: $8.85M
BCAB [@Biotechnology] is valued at $13.23M. QNCX’s [@Biotechnology] market capitalization is $8.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, QNCX is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 5 TA indicator(s) are bullish while QNCX’s TA Score has 4 bullish TA indicator(s).

  • BCAB’s TA Score: 5 bullish, 4 bearish.
  • QNCX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BCAB is a better buy in the short-term than QNCX.

Price Growth

BCAB (@Biotechnology) experienced а -32.40% price change this week, while QNCX (@Biotechnology) price change was -95.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

BCAB is expected to report earnings on Mar 19, 2026.

QNCX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCAB($13.2M) has a higher market cap than QNCX($8.85M). BCAB YTD gains are higher at: -63.026 vs. QNCX (-95.257). QNCX has higher annual earnings (EBITDA): -44.18M vs. BCAB (-65.71M). QNCX has more cash in the bank: 26.3M vs. BCAB (8.32M). BCAB has less debt than QNCX: BCAB (6.18M) vs QNCX (18M). BCAB (0) and QNCX (0) have equivalent revenues.
BCABQNCXBCAB / QNCX
Capitalization13.2M8.85M149%
EBITDA-65.71M-44.18M149%
Gain YTD-63.026-95.25766%
P/E RatioN/AN/A-
Revenue00-
Total Cash8.32M26.3M32%
Total Debt6.18M18M34%
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
99
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCABQNCX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 24 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BCAB
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCBS29.830.57
+1.95%
MetroCity Bankshares
AGO87.091.29
+1.50%
Assured Guaranty Ltd
VTR77.730.04
+0.05%
Ventas
TAVI10.48N/A
N/A
Tavia Acquisition Corp.
HOTH0.80-0.04
-4.33%
Hoth Therapeutics

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been closely correlated with VTGN. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCAB jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+11.06%
VTGN - BCAB
82%
Closely correlated
-3.20%
QNCX - BCAB
80%
Closely correlated
+9.28%
CALC - BCAB
77%
Closely correlated
+8.37%
LENZ - BCAB
76%
Closely correlated
-5.86%
GNTA - BCAB
72%
Closely correlated
-1.27%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been closely correlated with MREO. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if QNCX jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+9.28%
MREO - QNCX
86%
Closely correlated
-2.73%
CALC - QNCX
85%
Closely correlated
+8.37%
TPST - QNCX
84%
Closely correlated
-1.24%
RZLT - QNCX
83%
Closely correlated
-7.62%
GNTA - QNCX
83%
Closely correlated
-1.27%
More